From clinical decision-making to genomics, ethics, and lab science, these speakers anchor the conversations shaping what comes next
With PCRS 2026 just days away, anticipation is building across the reproductive medicine community. The Pacific Coast Reproductive Society (PCRS) has long been known for convening voices that don’t just present data, but actively shape how the field thinks, debates, and evolves. This year’s speaker lineup reinforces exactly why PCRS remains one of the most respected—and consequential—meetings on the calendar.
True to its mission, PCRS 2026 brings together clinicians, laboratory scientists, genetic counselors, legal experts, and advanced practice leaders, many of whom appear across multiple sessions. The result is not siloed expertise, but a dynamic, multidisciplinary dialogue that mirrors the complexity of modern fertility care.
The full speaker lineup and session details can be explored via the official PCRS 2026 schedule HERE.
Clinical Leadership & Evidence-Based Practice
Physician leadership anchors much of the 2026 program, with respected voices guiding conversations around outcomes, clinical decision-making, and the realities of delivering care in an evolving regulatory and scientific environment.
Notable contributors include Kurt Barnhart, MD, MSCE (University of Pennsylvania) and Eduardo Hariton, MD, MBA (RSC Bay Area), alongside faculty affiliated with Harvard Medical School, the University of Utah, the University of North Carolina, and other leading academic institutions.
Across sessions, these leaders bring a pragmatic lens to evidence-based practice—examining not only what the data say, but how clinicians operationalize evidence in real-world settings where patient expectations, access challenges, and ethical considerations intersect.
Laboratory Science & Translational Research
PCRS has always treated the laboratory as central—not adjacent—to reproductive medicine, and the 2026 program continues that tradition.
Laboratory and translational research perspectives are led by experts such as Joseph Conaghan, PhD, HCLD and Bec Holmes, PhD, HCLD (CCRM), as well as Pierre Comizzoli, DVM, MSc, PhD (National Institutes of Health) and Pranam Chatterjee, PhD (University of Pennsylvania).
Their sessions bridge foundational biology, technological innovation, and clinical application—reflecting PCRS’s emphasis on translational insight rather than isolated discovery. For embryologists, lab directors, and clinician-scientists alike, these discussions ground innovation in reproducibility, rigor, and patient relevance.
Genetics, Counseling & Patient Communication
As genomics becomes ever more integrated into fertility care, PCRS 2026 places a strong spotlight on the professionals navigating its complexity at the patient level.
Leaders including Rawan Awwad, CGC, Alleigh Boyd, MS, CGC, Jenna Miller, MS, CGC, and Christina Boots (Northwestern University) guide sessions on genetic testing, counseling challenges, ethical integration, and communication strategies in increasingly data-dense clinical encounters.
These conversations move beyond test selection, addressing how genetic information is contextualized, conveyed, and ethically applied—critical considerations as genomic tools expand faster than consensus guidelines.
Care Delivery, Ethics & Policy
PCRS’s multidisciplinary strength is perhaps most evident in sessions addressing care delivery, patient experience, ethics, and law.
Advanced practice and patient-centered perspectives are represented by Jamie Feingold, MSN, NP-C, WHNP-BC, C-RHI, Kate Devine, and Micah Hill (Shady Grove Fertility), offering insight into how systems, teams, and workflows shape outcomes.
Legal and regulatory considerations are anchored by Susan Crockin, JD (Georgetown University Law Center), whose contributions help ground innovation in legal reality—an increasingly critical balance in reproductive medicine today.
A Speaker Lineup That Reflects the PCRS Ethos
Taken together, the PCRS 2026 speaker roster reflects the Society’s core identity: rigorous science, real-world relevance, and thoughtful debate in a setting that values collegiality as much as expertise. It’s a program designed not just to inform, but to challenge assumptions and move conversations forward.
If You Want to Be in the Center of It All, Find Meitheal
PCRS 2026 isn’t just another meeting—it’s where ideas are tested, relationships are built, and the future of reproductive medicine takes shape.
Industry support plays a vital role in advancing the PCRS mission and Meitheal Pharmaceuticals is a proud supporter. Committed to expanding access to fertility care, Meitheal is excited to connect with clinicians, scientists, and leaders who share that mission.
If improving care, broadening access, and shaping the future of reproductive medicine matter to you, make time to meet Meitheal in Rancho Mirage.
With Meitheal as their partner, leading fertility pharmacies are taking the opportunity to:
✔ Diversify and increase their offerings
✔ Serve more fertility patients
✔ Partner with the leader in generic fertility medications, Meitheal Pharmaceuticals
If you work for a fertility pharmacy, it all starts with a friendly conversation. Just send us an email here: